1. Home
  2. BCRX vs DK Comparison

BCRX vs DK Comparison

Compare BCRX & DK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$7.40

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

HOLD

Current Price

$30.57

Market Cap

1.8B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
DK
Founded
1986
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Integrated oil Companies
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
BCRX
DK
Price
$7.40
$30.57
Analyst Decision
Strong Buy
Hold
Analyst Count
12
15
Target Price
$20.08
$35.53
AVG Volume (30 Days)
3.5M
1.3M
Earning Date
02-23-2026
02-24-2026
Dividend Yield
N/A
3.35%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$599,816,000.00
$10,667,200,000.00
Revenue This Year
$39.98
N/A
Revenue Next Year
$7.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.38
N/A
52 Week Low
$6.00
$11.03
52 Week High
$11.31
$43.50

Technical Indicators

Market Signals
Indicator
BCRX
DK
Relative Strength Index (RSI) 50.30 37.13
Support Level $7.52 $28.59
Resistance Level $8.05 $30.91
Average True Range (ATR) 0.31 1.23
MACD -0.01 0.21
Stochastic Oscillator 40.12 50.82

Price Performance

Historical Comparison
BCRX
DK

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

Share on Social Networks: